- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TS-25-0000396

Ekvira Formulations Private Limited
About Ekvira Formulations Private Limited
Data last updated:
Ekvira Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC124483. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Madhavi Bhupal Rao (Managing Director) and Manoher Rao Monari.
Its last annual general meeting (AGM) was held on 24 October 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at H.No.152/B 1st Phase Allwyn Colony Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2020, the company reported a revenue of ₹1.36 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹14.26 Lakh (net margin 10.5%) and EBITDA of ₹38.24 Lakh (EBITDA margin 28.1%).
As per MCA filings, the company has open charges of ₹87 Lakh on record.
Ekvira Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-25-0000396).
Company details
Recognitions & Rankings of Ekvira Formulations
Contact details
Ekvira Formulations Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No.152/B 1st Phase Allwyn Colony Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ekvira Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ekvira Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ekvira Formulations Private Limited, buy the company report.
Financials of Ekvira Formulations Private Limited
FY 2020 filings availableEkvira Formulations Private Limited reported revenue of ₹1.36 Cr (up 2361% YoY) for FY 2020.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹1.36 Cr | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹38.24 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹14.26 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 28.1% | |
| Net Profit Margin | 10.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Ekvira Formulations Private Limited, buy the company report.
Board of directors of Ekvira Formulations Private Limited
Ekvira Formulations has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhavi Bhupal Rao | Managing Director | 15 May 2018 | 8 Years 6 Months | Current |
| Manoher Rao Monari | Director | 15 May 2018 | 8 Years 6 Months | Current |
Peer comparison
Ekvira Formulations Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| HCR Formulations Private Limited | ₹1.37 Cr (FY 2025) | -34.0% | Ahmedabad, Gujarat, India | |||
| Torcium Biotech Private Limited | ₹1.36 Cr (FY 2025) | 6.0% | Jaipur, Rajasthan, India | |||
| Shree Vinayaka Life Sciences Private Limited | ₹1.36 Cr (FY 2025) | -65.0% | Hyderabad, Telangana, India | |||
| Ekvira Formulations Private Limitedthis company | ₹1.36 Cr (FY 2020) | ₹14.26 Lakh | 10.5% | 2361.0% | Hyderabad, Telangana, India | |
| Sankalpa Human Resource Development Corporation Limited | ₹1.36 Cr (FY 2021) | 283.0% | Pune, Maharashtra, India | |||
| Jyoti Simple Solutions Private Limited | ₹1.35 Cr (FY 2025) | -14.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Ekvira Formulations Private Limited, buy the company report.
Auditor
Ekvira Formulations Private Limited is audited by PENTYALA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PENTYALA & ASSOCIATES | FY 2020 | 020654S |
Shareholding
The shareholding of Ekvira Formulations Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ekvira Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Aug 2019 | 100290978 | State Bank of India | ₹87 Lakh | Open |
To see the full charge records of Ekvira Formulations Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ekvira Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ekvira Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ekvira Formulations has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Ekvira Formulations Private Limited, buy the company report.
Recent activity
Ekvira Formulations Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Nageshwar Rao Bhupal Rao ceased to be Director on 29 May 2019.
Frequently asked questions
Ekvira Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 May 2018 (8+ years old) and is registered under CIN U74999TG2018PTC124483.
Ekvira Formulations has 2 current directors:
- Madhavi Bhupal Rao - Managing Director
- Manoher Rao Monari - Director
The latest financial statements of Ekvira Formulations on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 24 October 2020. Year-wise statements from FY 2019 are in the company report.
No. Ekvira Formulations has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Ekvira Formulations is U74999TG2018PTC124483. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ekvira Formulations was incorporated on 15 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Ekvira Formulations by revenue are HCR Formulations Private Limited, Torcium Biotech Private Limited, Shree Vinayaka Life Sciences Private Limited, Sankalpa Human Resource Development Corporation Limited, Jyoti Simple Solutions Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nageshwar Rao Bhupal Rao ceased to be Director on 29 May 2019. Madhavi Bhupal Rao was appointed as Managing Director on 15 May 2018. Manoher Rao Monari was appointed as Director on 15 May 2018.
Yes, Ekvira Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-25-0000396).
The registered office of Ekvira Formulations is at H.No.152B 1st Phase Allwyn Colony Kukatpally, Hyderabad, Telangana, India – 500072.
Ekvira Formulations operates in the pharma industry, in the drug formulation and development segment.

